Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
AstraZeneca
Washington University School of Medicine
Essen Biotech
MacroGenics
Indiana University
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
University of Nebraska
University of Florida
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Ocellaris Pharma, Inc.
University of Southern California
Indiana University
Swiss Cancer Institute
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Transgene
HiFiBiO Therapeutics
Seattle Children's Hospital
TScan Therapeutics, Inc.
Bayer
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Young Adult Survivors United
Hadassah Medical Organization
British Columbia Cancer Agency
Valo Therapeutics Oy
Guangzhou FineImmune Biotechnology Co., LTD.
Fudan University